US4432871A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Immune adsorbent, adsorbing device and blood purifying apparatus
Assignee: Asahi Kasei Medical Co Ltd
•
Filing: 1982-01-15
•
Granted: 1984-02-21
•
Expires: 2002-01-15
Abstract
Abstract An adsorbing material for an autoantibody and/or immune complexes is provided. The adsorbing material has an insoluble carrier and an organic low-molecular-weight compound containing a hydrophobic compound, which is fixed to the insoluble carrier. The adsorbing material may be used in an adsorbing device, which has a vessel having fluid inlet and outlet openings with the adsorbing material being contained in the vessel. The adsorbing device may be used in a blood purifying apparatus for absorbing and removing an autoantibody and/or immune complexes from blood plasma, which apparatus has (a) a plasma separating device and (b) a blood-plasma mixing device, which are disposed in series in a blood circulation passage, and (c) a plasma purifying device comprising the adsorbing device disposed in a plasma recycle passage connected to the blood circulation passage to introduce plasma, separated in the plasma separating device, into the mixing device.
Inventors
- 👤 Maokuni Yamawaki
- 👤 Shozo Suzuki
- 👤 Tadaaki Furuta
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 15:42
CPC Classifications
A; A61; A61M; A61M1/00; A61M1/36; A61M1/3679; A61M1/3616; B; B01; B01D; B01D15/00; B01D15/08; B01J; B01J20/00; B01J20/30; B01J20/32; B01J20/3202; B01J20/3206; B01J20/3208; B01J20/321; B01J20/3231; B01J20/3242; B01J20/3244; B01J20/3246; B01J20/3248; B01J20/3253; B01J20/3255; B01D15/26; B01D15/32; B01D15/325; B01D15/327; B01D15/38; B01D15/3804; B01D15/3809
Claims Analysis
Total Claims: 19
Claim 1
Independent Claim
68 words
An adsorbing material for an autoantibody and/or immune complexes, which comprises (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said organic low-molecular-weight compound being fixed to the insoluble carrier by covalent bonding and having a molecular weight not higher than about 10,000.
Claim 2
Dependent Claim
68 words
An adsorbing material for an autoantibody and/or immune complexes, which comprises (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said organic low-molecular-weight compound being fixed to the insoluble carrier by covalent bonding and having a molecular weight not higher than about 10,000.
Claim 3
Dependent Claim
22 words
An adsorbing material as set forth in claim 1, wherein the hydrophobic compound is a compound containing at least one aromatic ring.
Claim 4
Dependent Claim
17 words
An adsorbing material as set forth in claim 2, wherein the aromatic ring is an indole ring.
Claim 5
Dependent Claim
34 words
An adsorbing material as set forth in claim 1, wherein the organic low-molecular-weight compound containing the hydrophobic compound is a derivative of a hydrophobic amino acid prepared by chemically modifying the hydrophobic amino acid.
Claim 6
Dependent Claim
16 words
An adsorbing material as set forth in claim 4, wherein the hydrophobic amino acid is tryptophane.
Claim 7
Dependent Claim
29 words
An adsorbing material as set forth in claim 1, wherein the insoluble carrier is of a particulate form having an average particle size of from 25 to 2,500 μm.
Claim 8
Dependent Claim
27 words
An adsorbing material as set forth in claim 1, wherein the insoluble carrier is of a fibrous form having a diameter of from 0.02 to 10 denier.
Claim 9
Dependent Claim
20 words
An adsorbing material as set forth in claim 1, wherein the insoluble carrier is a crosslinked copolymer containing hydroxyl groups.
Claim 10
Dependent Claim
28 words
An adsorbing material as set forth in claim 8, wherein the hydroxyl group-containing crosslinked copolymer is a crosslinked copolymer comprising vinyl alcohol units as the main constituent units.
Claim 11
Dependent Claim
47 words
An adsorbing material as set forth in claim 9, wherein the crosslinked copolymer, comprising vinyl alcohol units as the main constituent, is a crosslinked polyvinyl alcohol obtained by hydrolyzing a copolymer of a vinyl ester of a carboxylic acid with a vinyl compound containing an isocyanurate ring.
Claim 12
Dependent Claim
23 words
An adsorbing material as set forth in claim 1, wherein the organic low-molecular-weight compound has a molecular weight not higher than about 1,000.
Claim 13
Dependent Claim
88 words
An adsorbing device for an autoantibody and/or immune complexes, which comprises a vessel having fluid inlet and outlet openings and an adsorbing material contained in said vessel, said adsorbing material comprising (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said organic low-molecular-weight compound being fixed to the insoluble carrier by covalent bonding and having a molecular weight not higher than about 10,000.
Claim 14
Dependent Claim
88 words
An adsorbing device for an autoantibody and/or immune complexes, which comprises a vessel having fluid inlet and outlet openings and an adsorbing material contained in said vessel, said adsorbing material comprising (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said organic low-molecular-weight compound being fixed to the insoluble carrier by covalent bonding and having a molecular weight not higher than about 10,000.
Claim 15
Dependent Claim
168 words
A blood purifying apparatus for adsorbing and removing an autoantibody and/or immune complexes from blood plasma, which comprises a blood introduction zone, a purified blood discharge zone, a blood circulation passage including a plasma separating device and a blood-plasma mixing device, and a plasma recycle passage connected to said blood circulation passage to introduce plasma, separated in the plasma separating device, into said mixing device, through a plasma purifying device, said circulation passage and recycle passage being disposed between said blood introduction zone and said purified blood discharge zone, wherein said plasma purifying device comprises a vessel having fluid inlet and outlet openings and an adsorbing material contained in said vessel, said adsorbing material comprising (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said low-molecular-weight compound being fixed to the insoluble carrier and having a molecular weight not higher than about 10,000.
Claim 16
Dependent Claim
168 words
A blood purifying apparatus for adsorbing and removing an autoantibody and/or immune complexes from blood plasma, which comprises a blood introduction zone, a purified blood discharge zone, a blood circulation passage including a plasma separating device and a blood-plasma mixing device, and a plasma recycle passage connected to said blood circulation passage to introduce plasma, separated in the plasma separating device, into said mixing device, through a plasma purifying device, said circulation passage and recycle passage being disposed between said blood introduction zone and said purified blood discharge zone, wherein said plasma purifying device comprises a vessel having fluid inlet and outlet openings and an adsorbing material contained in said vessel, said adsorbing material comprising (a) an insoluble carrier and (b) an organic low-molecular-weight compound containing a hydrophobic compound having a solubility of not more than 100 millimoles in one dl of a physiological saline solution at 25° C., said low-molecular-weight compound being fixed to the insoluble carrier and having a molecular weight not higher than about 10,000.
Claim 17
Dependent Claim
61 words
A blood purifying apparatus as set forth in claim 13, wherein the plasma separating device comprises a blood inlet, an outlet for concentrated blood, a porous membrane allowing passage of plasma components, but not allowing passage of hematocyte components, a space for temporarily storing separated plasma and a plasma outlet, separated from said blood inlet and outlet by said porous membrane.
Claim 18
Dependent Claim
45 words
A blood purifying apparatus as set forth in claim 14, wherein the porous membrane of the plasma separating device is a porous membrane having micropores having an average pore size of 0.05 to 2.0 μm, which are uniformly distributed on the surface of the membrane.
Claim 19
Dependent Claim
42 words
A blood purifying apparatus as set forth in claim 13, wherein the plasma separating device is a centrifugal separating device in which blood is continuously introduced from one side and hematocyte-concentrated blood and plasma are continuously discharged, independently, from the other side.
References Cited (Backward Citations)
US3442819A
Cited
US4261828A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-02-20 | 1987-08-22 | 1988-02-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-02-20 | 1991-08-22 | 1992-02-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-02-20 | 1995-08-22 | 1996-02-21 | $7700.00 | Window Closed / Lapsed |